Dr. Roach: Comparing treatments for BPH, from tamsulosin to surgery

Before having cataract surgery, any person who has ever taken an alpha blocker should tell their eye surgeon. Tamsulosin is ...

FDA Approves the Zenflow Spring® Implant and Delivery System for First-Line Interventional Therapy of Patients with Benign Prostatic Hyperplasia (BPH)

Year DurabilityInnovative Design Allows for Only Tailored BPH Approach that Preserves Natural AnatomySOUTH SAN ...
Renal & Urology News

FDA Approves ProVee® Urethral Stent for BPH Treatment

The prostatic urethral stent for relief of lower urinary tract symptoms from benign prostatic hyperplasia (BPH) was tested in the ProVide trial.
MassDevice

ProVerum, Zenflow win FDA nods for BPH treatment devices

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...
European Medical Journal

Blood-Based Inflammation Markers Predict Severity of Enlarged Prostate Symptoms

Study finds simple inflammatory blood tests may signal severe BPH symptoms. Discover which markers showed the strongest predictive power.

FDA Approves the ProVee System - the First of a New Generation of Prostatic Urethral Stents for Treatment of BPH

ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it has received FDA approval for its ...
Managed Healthcare Executive

New test may solve the specificity and false-positive problems of the PSA test for prostate cancer

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Medscape

Do Lower Urinary Tract Symptoms Lead to Unnecessary Prostate Cancer Testing?

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and ...